Global Human Insulin Drugs And Delivery Devices Market Insights, Forecast to 2029
This report presents an overview of global market for Human Insulin Drugs And Delivery Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Human Insulin Drugs And Delivery Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Insulin Drugs And Delivery Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Insulin Drugs And Delivery Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Human Insulin Drugs And Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Human Insulin Drugs And Delivery Devices sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Medtronic, Insulet and Ypsomed, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Insulin Drugs And Delivery Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Human Insulin Drugs And Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Insulin Drugs And Delivery Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Human Insulin Drugs And Delivery Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Insulin Drugs And Delivery Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Insulin Drugs And Delivery Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Human Insulin Drugs And Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Human Insulin Drugs And Delivery Devices sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Medtronic, Insulet and Ypsomed, etc.
By Company
- Novo Nordisk
- Sanofi Aventis
- Eli Lilly
- Biocon
- Julphar
- Exir
- Medtronic
- Insulet
- Ypsomed
- Becton Dickinson
- Insulin Pumps
- Insulin Pens
- Insulin Syringes
- Basal or Long Acting Insulins
- Bolus or Fast-Acting Insulins
- Hospital
- Household
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Insulin Drugs And Delivery Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Human Insulin Drugs And Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Insulin Drugs And Delivery Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Human Insulin Drugs And Delivery Devices Product Introduction
1.2 Market by Type
1.2.1 Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Insulin Pumps
1.2.3 Insulin Pens
1.2.4 Insulin Syringes
1.2.5 Basal or Long Acting Insulins
1.2.6 Bolus or Fast-Acting Insulins
1.3 Market by Application
1.3.1 Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Household
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Human Insulin Drugs And Delivery Devices Sales Estimates and Forecasts 2018-2029
2.2 Global Human Insulin Drugs And Delivery Devices Revenue by Region
2.2.1 Global Human Insulin Drugs And Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2023)
2.2.3 Global Human Insulin Drugs And Delivery Devices Revenue by Region (2024-2029)
2.2.4 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2018-2029)
2.3 Global Human Insulin Drugs And Delivery Devices Sales Estimates and Forecasts 2018-2029
2.4 Global Human Insulin Drugs And Delivery Devices Sales by Region
2.4.1 Global Human Insulin Drugs And Delivery Devices Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Insulin Drugs And Delivery Devices Sales by Region (2018-2023)
2.4.3 Global Human Insulin Drugs And Delivery Devices Sales by Region (2024-2029)
2.4.4 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers
3.1.1 Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers (2018-2023)
3.1.2 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin Drugs And Delivery Devices in 2022
3.2 Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers
3.2.1 Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2018-2023)
3.2.2 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Drugs And Delivery Devices Revenue in 2022
3.3 Global Key Players of Human Insulin Drugs And Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Human Insulin Drugs And Delivery Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Insulin Drugs And Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Product Offered and Application
3.8 Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Human Insulin Drugs And Delivery Devices Sales by Type
4.1.1 Global Human Insulin Drugs And Delivery Devices Historical Sales by Type (2018-2023)
4.1.2 Global Human Insulin Drugs And Delivery Devices Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
4.2 Global Human Insulin Drugs And Delivery Devices Revenue by Type
4.2.1 Global Human Insulin Drugs And Delivery Devices Historical Revenue by Type (2018-2023)
4.2.2 Global Human Insulin Drugs And Delivery Devices Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
4.3 Global Human Insulin Drugs And Delivery Devices Price by Type
4.3.1 Global Human Insulin Drugs And Delivery Devices Price by Type (2018-2023)
4.3.2 Global Human Insulin Drugs And Delivery Devices Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Human Insulin Drugs And Delivery Devices Sales by Application
5.1.1 Global Human Insulin Drugs And Delivery Devices Historical Sales by Application (2018-2023)
5.1.2 Global Human Insulin Drugs And Delivery Devices Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
5.2 Global Human Insulin Drugs And Delivery Devices Revenue by Application
5.2.1 Global Human Insulin Drugs And Delivery Devices Historical Revenue by Application (2018-2023)
5.2.2 Global Human Insulin Drugs And Delivery Devices Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
5.3 Global Human Insulin Drugs And Delivery Devices Price by Application
5.3.1 Global Human Insulin Drugs And Delivery Devices Price by Application (2018-2023)
5.3.2 Global Human Insulin Drugs And Delivery Devices Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Human Insulin Drugs And Delivery Devices Market Size by Type
6.1.1 US & Canada Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
6.1.2 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
6.2 US & Canada Human Insulin Drugs And Delivery Devices Market Size by Application
6.2.1 US & Canada Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
6.2.2 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
6.3 US & Canada Human Insulin Drugs And Delivery Devices Market Size by Country
6.3.1 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Insulin Drugs And Delivery Devices Sales by Country (2018-2029)
6.3.3 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Human Insulin Drugs And Delivery Devices Market Size by Type
7.1.1 Europe Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
7.1.2 Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
7.2 Europe Human Insulin Drugs And Delivery Devices Market Size by Application
7.2.1 Europe Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
7.2.2 Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
7.3 Europe Human Insulin Drugs And Delivery Devices Market Size by Country
7.3.1 Europe Human Insulin Drugs And Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Insulin Drugs And Delivery Devices Sales by Country (2018-2029)
7.3.3 Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Human Insulin Drugs And Delivery Devices Market Size
8.1.1 China Human Insulin Drugs And Delivery Devices Sales (2018-2029)
8.1.2 China Human Insulin Drugs And Delivery Devices Revenue (2018-2029)
8.2 China Human Insulin Drugs And Delivery Devices Market Size by Application
8.2.1 China Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
8.2.2 China Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Human Insulin Drugs And Delivery Devices Market Size by Type
9.1.1 Asia Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
9.1.2 Asia Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
9.2 Asia Human Insulin Drugs And Delivery Devices Market Size by Application
9.2.1 Asia Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
9.2.2 Asia Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
9.3 Asia Human Insulin Drugs And Delivery Devices Sales by Region
9.3.1 Asia Human Insulin Drugs And Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2029)
9.3.3 Asia Human Insulin Drugs And Delivery Devices Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Novo Nordisk Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi Aventis
11.2.1 Sanofi Aventis Company Information
11.2.2 Sanofi Aventis Overview
11.2.3 Sanofi Aventis Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sanofi Aventis Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Aventis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Eli Lilly Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Biocon
11.4.1 Biocon Company Information
11.4.2 Biocon Overview
11.4.3 Biocon Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Biocon Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biocon Recent Developments
11.5 Julphar
11.5.1 Julphar Company Information
11.5.2 Julphar Overview
11.5.3 Julphar Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Julphar Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Julphar Recent Developments
11.6 Exir
11.6.1 Exir Company Information
11.6.2 Exir Overview
11.6.3 Exir Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Exir Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Exir Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Information
11.7.2 Medtronic Overview
11.7.3 Medtronic Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Medtronic Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Recent Developments
11.8 Insulet
11.8.1 Insulet Company Information
11.8.2 Insulet Overview
11.8.3 Insulet Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Insulet Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Insulet Recent Developments
11.9 Ypsomed
11.9.1 Ypsomed Company Information
11.9.2 Ypsomed Overview
11.9.3 Ypsomed Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Ypsomed Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ypsomed Recent Developments
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Information
11.10.2 Becton Dickinson Overview
11.10.3 Becton Dickinson Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Becton Dickinson Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Becton Dickinson Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Human Insulin Drugs And Delivery Devices Industry Chain Analysis
12.2 Human Insulin Drugs And Delivery Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Insulin Drugs And Delivery Devices Production Mode & Process
12.4 Human Insulin Drugs And Delivery Devices Sales and Marketing
12.4.1 Human Insulin Drugs And Delivery Devices Sales Channels
12.4.2 Human Insulin Drugs And Delivery Devices Distributors
12.5 Human Insulin Drugs And Delivery Devices Customers
13 MARKET DYNAMICS
13.1 Human Insulin Drugs And Delivery Devices Industry Trends
13.2 Human Insulin Drugs And Delivery Devices Market Drivers
13.3 Human Insulin Drugs And Delivery Devices Market Challenges
13.4 Human Insulin Drugs And Delivery Devices Market Restraints
14 KEY FINDINGS IN THE GLOBAL HUMAN INSULIN DRUGS AND DELIVERY DEVICES STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Human Insulin Drugs And Delivery Devices Product Introduction
1.2 Market by Type
1.2.1 Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Insulin Pumps
1.2.3 Insulin Pens
1.2.4 Insulin Syringes
1.2.5 Basal or Long Acting Insulins
1.2.6 Bolus or Fast-Acting Insulins
1.3 Market by Application
1.3.1 Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Household
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Human Insulin Drugs And Delivery Devices Sales Estimates and Forecasts 2018-2029
2.2 Global Human Insulin Drugs And Delivery Devices Revenue by Region
2.2.1 Global Human Insulin Drugs And Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2023)
2.2.3 Global Human Insulin Drugs And Delivery Devices Revenue by Region (2024-2029)
2.2.4 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2018-2029)
2.3 Global Human Insulin Drugs And Delivery Devices Sales Estimates and Forecasts 2018-2029
2.4 Global Human Insulin Drugs And Delivery Devices Sales by Region
2.4.1 Global Human Insulin Drugs And Delivery Devices Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Insulin Drugs And Delivery Devices Sales by Region (2018-2023)
2.4.3 Global Human Insulin Drugs And Delivery Devices Sales by Region (2024-2029)
2.4.4 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers
3.1.1 Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers (2018-2023)
3.1.2 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin Drugs And Delivery Devices in 2022
3.2 Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers
3.2.1 Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2018-2023)
3.2.2 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Drugs And Delivery Devices Revenue in 2022
3.3 Global Key Players of Human Insulin Drugs And Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Human Insulin Drugs And Delivery Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Insulin Drugs And Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Product Offered and Application
3.8 Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Human Insulin Drugs And Delivery Devices Sales by Type
4.1.1 Global Human Insulin Drugs And Delivery Devices Historical Sales by Type (2018-2023)
4.1.2 Global Human Insulin Drugs And Delivery Devices Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
4.2 Global Human Insulin Drugs And Delivery Devices Revenue by Type
4.2.1 Global Human Insulin Drugs And Delivery Devices Historical Revenue by Type (2018-2023)
4.2.2 Global Human Insulin Drugs And Delivery Devices Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
4.3 Global Human Insulin Drugs And Delivery Devices Price by Type
4.3.1 Global Human Insulin Drugs And Delivery Devices Price by Type (2018-2023)
4.3.2 Global Human Insulin Drugs And Delivery Devices Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Human Insulin Drugs And Delivery Devices Sales by Application
5.1.1 Global Human Insulin Drugs And Delivery Devices Historical Sales by Application (2018-2023)
5.1.2 Global Human Insulin Drugs And Delivery Devices Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
5.2 Global Human Insulin Drugs And Delivery Devices Revenue by Application
5.2.1 Global Human Insulin Drugs And Delivery Devices Historical Revenue by Application (2018-2023)
5.2.2 Global Human Insulin Drugs And Delivery Devices Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
5.3 Global Human Insulin Drugs And Delivery Devices Price by Application
5.3.1 Global Human Insulin Drugs And Delivery Devices Price by Application (2018-2023)
5.3.2 Global Human Insulin Drugs And Delivery Devices Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Human Insulin Drugs And Delivery Devices Market Size by Type
6.1.1 US & Canada Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
6.1.2 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
6.2 US & Canada Human Insulin Drugs And Delivery Devices Market Size by Application
6.2.1 US & Canada Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
6.2.2 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
6.3 US & Canada Human Insulin Drugs And Delivery Devices Market Size by Country
6.3.1 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Insulin Drugs And Delivery Devices Sales by Country (2018-2029)
6.3.3 US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Human Insulin Drugs And Delivery Devices Market Size by Type
7.1.1 Europe Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
7.1.2 Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
7.2 Europe Human Insulin Drugs And Delivery Devices Market Size by Application
7.2.1 Europe Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
7.2.2 Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
7.3 Europe Human Insulin Drugs And Delivery Devices Market Size by Country
7.3.1 Europe Human Insulin Drugs And Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Insulin Drugs And Delivery Devices Sales by Country (2018-2029)
7.3.3 Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Human Insulin Drugs And Delivery Devices Market Size
8.1.1 China Human Insulin Drugs And Delivery Devices Sales (2018-2029)
8.1.2 China Human Insulin Drugs And Delivery Devices Revenue (2018-2029)
8.2 China Human Insulin Drugs And Delivery Devices Market Size by Application
8.2.1 China Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
8.2.2 China Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Human Insulin Drugs And Delivery Devices Market Size by Type
9.1.1 Asia Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
9.1.2 Asia Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
9.2 Asia Human Insulin Drugs And Delivery Devices Market Size by Application
9.2.1 Asia Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
9.2.2 Asia Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
9.3 Asia Human Insulin Drugs And Delivery Devices Sales by Region
9.3.1 Asia Human Insulin Drugs And Delivery Devices Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2029)
9.3.3 Asia Human Insulin Drugs And Delivery Devices Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Novo Nordisk Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi Aventis
11.2.1 Sanofi Aventis Company Information
11.2.2 Sanofi Aventis Overview
11.2.3 Sanofi Aventis Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sanofi Aventis Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Aventis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Eli Lilly Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Biocon
11.4.1 Biocon Company Information
11.4.2 Biocon Overview
11.4.3 Biocon Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Biocon Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biocon Recent Developments
11.5 Julphar
11.5.1 Julphar Company Information
11.5.2 Julphar Overview
11.5.3 Julphar Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Julphar Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Julphar Recent Developments
11.6 Exir
11.6.1 Exir Company Information
11.6.2 Exir Overview
11.6.3 Exir Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Exir Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Exir Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Information
11.7.2 Medtronic Overview
11.7.3 Medtronic Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Medtronic Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Recent Developments
11.8 Insulet
11.8.1 Insulet Company Information
11.8.2 Insulet Overview
11.8.3 Insulet Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Insulet Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Insulet Recent Developments
11.9 Ypsomed
11.9.1 Ypsomed Company Information
11.9.2 Ypsomed Overview
11.9.3 Ypsomed Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Ypsomed Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ypsomed Recent Developments
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Information
11.10.2 Becton Dickinson Overview
11.10.3 Becton Dickinson Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Becton Dickinson Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Becton Dickinson Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Human Insulin Drugs And Delivery Devices Industry Chain Analysis
12.2 Human Insulin Drugs And Delivery Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Insulin Drugs And Delivery Devices Production Mode & Process
12.4 Human Insulin Drugs And Delivery Devices Sales and Marketing
12.4.1 Human Insulin Drugs And Delivery Devices Sales Channels
12.4.2 Human Insulin Drugs And Delivery Devices Distributors
12.5 Human Insulin Drugs And Delivery Devices Customers
13 MARKET DYNAMICS
13.1 Human Insulin Drugs And Delivery Devices Industry Trends
13.2 Human Insulin Drugs And Delivery Devices Market Drivers
13.3 Human Insulin Drugs And Delivery Devices Market Challenges
13.4 Human Insulin Drugs And Delivery Devices Market Restraints
14 KEY FINDINGS IN THE GLOBAL HUMAN INSULIN DRUGS AND DELIVERY DEVICES STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Insulin Pumps
Table 3. Major Manufacturers of Insulin Pens
Table 4. Major Manufacturers of Insulin Syringes
Table 5. Major Manufacturers of Basal or Long Acting Insulins
Table 6. Major Manufacturers of Bolus or Fast-Acting Insulins
Table 7. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Human Insulin Drugs And Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2018-2023)
Table 12. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2024-2029)
Table 13. Global Human Insulin Drugs And Delivery Devices Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Human Insulin Drugs And Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 15. Global Human Insulin Drugs And Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 16. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2018-2023)
Table 17. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2024-2029)
Table 18. Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers (2018-2023) & (K Units)
Table 19. Global Human Insulin Drugs And Delivery Devices Sales Share by Manufacturers (2018-2023)
Table 20. Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Human Insulin Drugs And Delivery Devices Revenue Share by Manufacturers (2018-2023)
Table 22. Global Key Players of Human Insulin Drugs And Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Human Insulin Drugs And Delivery Devices Price by Manufacturers 2018-2023 (USD/Unit)
Table 24. Global Human Insulin Drugs And Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Human Insulin Drugs And Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs And Delivery Devices as of 2022)
Table 26. Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Product Offered and Application
Table 28. Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 31. Global Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 32. Global Human Insulin Drugs And Delivery Devices Sales Share by Type (2018-2023)
Table 33. Global Human Insulin Drugs And Delivery Devices Sales Share by Type (2024-2029)
Table 34. Global Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Human Insulin Drugs And Delivery Devices Revenue Share by Type (2018-2023)
Table 37. Global Human Insulin Drugs And Delivery Devices Revenue Share by Type (2024-2029)
Table 38. Human Insulin Drugs And Delivery Devices Price by Type (2018-2023) & (USD/Unit)
Table 39. Global Human Insulin Drugs And Delivery Devices Price Forecast by Type (2024-2029) & (USD/Unit)
Table 40. Global Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 41. Global Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 42. Global Human Insulin Drugs And Delivery Devices Sales Share by Application (2018-2023)
Table 43. Global Human Insulin Drugs And Delivery Devices Sales Share by Application (2024-2029)
Table 44. Global Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Human Insulin Drugs And Delivery Devices Revenue Share by Application (2018-2023)
Table 47. Global Human Insulin Drugs And Delivery Devices Revenue Share by Application (2024-2029)
Table 48. Human Insulin Drugs And Delivery Devices Price by Application (2018-2023) & (USD/Unit)
Table 49. Global Human Insulin Drugs And Delivery Devices Price Forecast by Application (2024-2029) & (USD/Unit)
Table 50. US & Canada Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 51. US & Canada Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 53. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 55. US & Canada Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 57. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 60. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Human Insulin Drugs And Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 62. US & Canada Human Insulin Drugs And Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 63. Europe Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 64. Europe Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 65. Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 66. Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 68. Europe Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 69. Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 70. Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 73. Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Human Insulin Drugs And Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 75. Europe Human Insulin Drugs And Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 76. China Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 77. China Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 78. China Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 79. China Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 81. China Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 82. China Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 83. China Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 85. Asia Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 86. Asia Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 87. Asia Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 89. Asia Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 90. Asia Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 91. Asia Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 94. Asia Human Insulin Drugs And Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Human Insulin Drugs And Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 96. Asia Human Insulin Drugs And Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 98. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 100. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 102. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 110. Novo Nordisk Company Information
Table 111. Novo Nordisk Description and Major Businesses
Table 112. Novo Nordisk Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Novo Nordisk Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novo Nordisk Recent Developments
Table 115. Sanofi Aventis Company Information
Table 116. Sanofi Aventis Description and Major Businesses
Table 117. Sanofi Aventis Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Sanofi Aventis Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi Aventis Recent Developments
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Description and Major Businesses
Table 122. Eli Lilly Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Eli Lilly Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Lilly Recent Developments
Table 125. Biocon Company Information
Table 126. Biocon Description and Major Businesses
Table 127. Biocon Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Biocon Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Biocon Recent Developments
Table 130. Julphar Company Information
Table 131. Julphar Description and Major Businesses
Table 132. Julphar Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Julphar Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Julphar Recent Developments
Table 135. Exir Company Information
Table 136. Exir Description and Major Businesses
Table 137. Exir Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Exir Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Exir Recent Developments
Table 140. Medtronic Company Information
Table 141. Medtronic Description and Major Businesses
Table 142. Medtronic Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Medtronic Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Medtronic Recent Developments
Table 145. Insulet Company Information
Table 146. Insulet Description and Major Businesses
Table 147. Insulet Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Insulet Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Insulet Recent Developments
Table 150. Ypsomed Company Information
Table 151. Ypsomed Description and Major Businesses
Table 152. Ypsomed Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Ypsomed Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Ypsomed Recent Developments
Table 155. Becton Dickinson Company Information
Table 156. Becton Dickinson Description and Major Businesses
Table 157. Becton Dickinson Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Becton Dickinson Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Becton Dickinson Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Human Insulin Drugs And Delivery Devices Distributors List
Table 163. Human Insulin Drugs And Delivery Devices Customers List
Table 164. Human Insulin Drugs And Delivery Devices Market Trends
Table 165. Human Insulin Drugs And Delivery Devices Market Drivers
Table 166. Human Insulin Drugs And Delivery Devices Market Challenges
Table 167. Human Insulin Drugs And Delivery Devices Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 1. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Insulin Pumps
Table 3. Major Manufacturers of Insulin Pens
Table 4. Major Manufacturers of Insulin Syringes
Table 5. Major Manufacturers of Basal or Long Acting Insulins
Table 6. Major Manufacturers of Bolus or Fast-Acting Insulins
Table 7. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Human Insulin Drugs And Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2018-2023)
Table 12. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2024-2029)
Table 13. Global Human Insulin Drugs And Delivery Devices Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Human Insulin Drugs And Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 15. Global Human Insulin Drugs And Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 16. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2018-2023)
Table 17. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2024-2029)
Table 18. Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers (2018-2023) & (K Units)
Table 19. Global Human Insulin Drugs And Delivery Devices Sales Share by Manufacturers (2018-2023)
Table 20. Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Human Insulin Drugs And Delivery Devices Revenue Share by Manufacturers (2018-2023)
Table 22. Global Key Players of Human Insulin Drugs And Delivery Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Human Insulin Drugs And Delivery Devices Price by Manufacturers 2018-2023 (USD/Unit)
Table 24. Global Human Insulin Drugs And Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Human Insulin Drugs And Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs And Delivery Devices as of 2022)
Table 26. Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Product Offered and Application
Table 28. Global Key Manufacturers of Human Insulin Drugs And Delivery Devices, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 31. Global Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 32. Global Human Insulin Drugs And Delivery Devices Sales Share by Type (2018-2023)
Table 33. Global Human Insulin Drugs And Delivery Devices Sales Share by Type (2024-2029)
Table 34. Global Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Human Insulin Drugs And Delivery Devices Revenue Share by Type (2018-2023)
Table 37. Global Human Insulin Drugs And Delivery Devices Revenue Share by Type (2024-2029)
Table 38. Human Insulin Drugs And Delivery Devices Price by Type (2018-2023) & (USD/Unit)
Table 39. Global Human Insulin Drugs And Delivery Devices Price Forecast by Type (2024-2029) & (USD/Unit)
Table 40. Global Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 41. Global Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 42. Global Human Insulin Drugs And Delivery Devices Sales Share by Application (2018-2023)
Table 43. Global Human Insulin Drugs And Delivery Devices Sales Share by Application (2024-2029)
Table 44. Global Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Human Insulin Drugs And Delivery Devices Revenue Share by Application (2018-2023)
Table 47. Global Human Insulin Drugs And Delivery Devices Revenue Share by Application (2024-2029)
Table 48. Human Insulin Drugs And Delivery Devices Price by Application (2018-2023) & (USD/Unit)
Table 49. Global Human Insulin Drugs And Delivery Devices Price Forecast by Application (2024-2029) & (USD/Unit)
Table 50. US & Canada Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 51. US & Canada Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 53. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 55. US & Canada Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 57. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 60. US & Canada Human Insulin Drugs And Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Human Insulin Drugs And Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 62. US & Canada Human Insulin Drugs And Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 63. Europe Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 64. Europe Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 65. Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 66. Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 68. Europe Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 69. Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 70. Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 73. Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Human Insulin Drugs And Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 75. Europe Human Insulin Drugs And Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 76. China Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 77. China Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 78. China Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 79. China Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 81. China Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 82. China Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 83. China Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 85. Asia Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 86. Asia Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 87. Asia Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 89. Asia Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 90. Asia Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 91. Asia Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Human Insulin Drugs And Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 94. Asia Human Insulin Drugs And Delivery Devices Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Human Insulin Drugs And Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 96. Asia Human Insulin Drugs And Delivery Devices Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 98. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 100. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 102. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2024-2029) & (K Units)
Table 110. Novo Nordisk Company Information
Table 111. Novo Nordisk Description and Major Businesses
Table 112. Novo Nordisk Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Novo Nordisk Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novo Nordisk Recent Developments
Table 115. Sanofi Aventis Company Information
Table 116. Sanofi Aventis Description and Major Businesses
Table 117. Sanofi Aventis Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Sanofi Aventis Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi Aventis Recent Developments
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Description and Major Businesses
Table 122. Eli Lilly Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Eli Lilly Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Lilly Recent Developments
Table 125. Biocon Company Information
Table 126. Biocon Description and Major Businesses
Table 127. Biocon Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Biocon Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Biocon Recent Developments
Table 130. Julphar Company Information
Table 131. Julphar Description and Major Businesses
Table 132. Julphar Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Julphar Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Julphar Recent Developments
Table 135. Exir Company Information
Table 136. Exir Description and Major Businesses
Table 137. Exir Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Exir Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Exir Recent Developments
Table 140. Medtronic Company Information
Table 141. Medtronic Description and Major Businesses
Table 142. Medtronic Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Medtronic Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Medtronic Recent Developments
Table 145. Insulet Company Information
Table 146. Insulet Description and Major Businesses
Table 147. Insulet Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Insulet Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Insulet Recent Developments
Table 150. Ypsomed Company Information
Table 151. Ypsomed Description and Major Businesses
Table 152. Ypsomed Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Ypsomed Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Ypsomed Recent Developments
Table 155. Becton Dickinson Company Information
Table 156. Becton Dickinson Description and Major Businesses
Table 157. Becton Dickinson Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Becton Dickinson Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Becton Dickinson Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Human Insulin Drugs And Delivery Devices Distributors List
Table 163. Human Insulin Drugs And Delivery Devices Customers List
Table 164. Human Insulin Drugs And Delivery Devices Market Trends
Table 165. Human Insulin Drugs And Delivery Devices Market Drivers
Table 166. Human Insulin Drugs And Delivery Devices Market Challenges
Table 167. Human Insulin Drugs And Delivery Devices Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Human Insulin Drugs And Delivery Devices Product Picture
Figure 2. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Insulin Drugs And Delivery Devices Market Share by Type in 2022 & 2029
Figure 4. Insulin Pumps Product Picture
Figure 5. Insulin Pens Product Picture
Figure 6. Insulin Syringes Product Picture
Figure 7. Basal or Long Acting Insulins Product Picture
Figure 8. Bolus or Fast-Acting Insulins Product Picture
Figure 9. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Human Insulin Drugs And Delivery Devices Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Household
Figure 13. Human Insulin Drugs And Delivery Devices Report Years Considered
Figure 14. Global Human Insulin Drugs And Delivery Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Insulin Drugs And Delivery Devices Revenue 2018-2029 (US$ Million)
Figure 16. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2018-2029)
Figure 18. Global Human Insulin Drugs And Delivery Devices Sales 2018-2029 ((K Units)
Figure 19. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 25. China Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Human Insulin Drugs And Delivery Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Insulin Drugs And Delivery Devices in the World: Market Share by Human Insulin Drugs And Delivery Devices Revenue in 2022
Figure 32. Global Human Insulin Drugs And Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 34. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 35. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 36. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Human Insulin Drugs And Delivery Devices Revenue Share by Country (2018-2029)
Figure 42. US & Canada Human Insulin Drugs And Delivery Devices Sales Share by Country (2018-2029)
Figure 43. U.S. Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 46. Europe Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 47. Europe Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 48. Europe Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 49. Europe Human Insulin Drugs And Delivery Devices Revenue Share by Country (2018-2029)
Figure 50. Europe Human Insulin Drugs And Delivery Devices Sales Share by Country (2018-2029)
Figure 51. Germany Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 52. France Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 56. China Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 57. China Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 58. China Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 59. China Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 60. Asia Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 61. Asia Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 62. Asia Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 63. Asia Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 64. Asia Human Insulin Drugs And Delivery Devices Revenue Share by Region (2018-2029)
Figure 65. Asia Human Insulin Drugs And Delivery Devices Sales Share by Region (2018-2029)
Figure 66. Japan Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 70. India Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales Share by Country (2018-2029)
Figure 77. Brazil Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 82. Human Insulin Drugs And Delivery Devices Value Chain
Figure 83. Human Insulin Drugs And Delivery Devices Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Figure 1. Human Insulin Drugs And Delivery Devices Product Picture
Figure 2. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Insulin Drugs And Delivery Devices Market Share by Type in 2022 & 2029
Figure 4. Insulin Pumps Product Picture
Figure 5. Insulin Pens Product Picture
Figure 6. Insulin Syringes Product Picture
Figure 7. Basal or Long Acting Insulins Product Picture
Figure 8. Bolus or Fast-Acting Insulins Product Picture
Figure 9. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Human Insulin Drugs And Delivery Devices Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Household
Figure 13. Human Insulin Drugs And Delivery Devices Report Years Considered
Figure 14. Global Human Insulin Drugs And Delivery Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Insulin Drugs And Delivery Devices Revenue 2018-2029 (US$ Million)
Figure 16. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2018-2029)
Figure 18. Global Human Insulin Drugs And Delivery Devices Sales 2018-2029 ((K Units)
Figure 19. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 25. China Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Human Insulin Drugs And Delivery Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Insulin Drugs And Delivery Devices in the World: Market Share by Human Insulin Drugs And Delivery Devices Revenue in 2022
Figure 32. Global Human Insulin Drugs And Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 34. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 35. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 36. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Human Insulin Drugs And Delivery Devices Revenue Share by Country (2018-2029)
Figure 42. US & Canada Human Insulin Drugs And Delivery Devices Sales Share by Country (2018-2029)
Figure 43. U.S. Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 46. Europe Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 47. Europe Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 48. Europe Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 49. Europe Human Insulin Drugs And Delivery Devices Revenue Share by Country (2018-2029)
Figure 50. Europe Human Insulin Drugs And Delivery Devices Sales Share by Country (2018-2029)
Figure 51. Germany Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 52. France Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 56. China Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 57. China Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 58. China Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 59. China Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 60. Asia Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 61. Asia Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 62. Asia Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 63. Asia Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 64. Asia Human Insulin Drugs And Delivery Devices Revenue Share by Region (2018-2029)
Figure 65. Asia Human Insulin Drugs And Delivery Devices Sales Share by Region (2018-2029)
Figure 66. Japan Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 70. India Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Human Insulin Drugs And Delivery Devices Sales Share by Country (2018-2029)
Figure 77. Brazil Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Human Insulin Drugs And Delivery Devices Revenue (2018-2029) & (US$ Million)
Figure 82. Human Insulin Drugs And Delivery Devices Value Chain
Figure 83. Human Insulin Drugs And Delivery Devices Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
